Our lab studies the immune response to cancer with the goal of developing immune-based strategies to prevent, detect and treat cancer. We use clinical specimens and murine models to investigate the complex interaction between the immune system and cancer at distinct stages of disease, including tumour initiation, progression, metastasis and recurrence. In collaboration with other groups, we are developing a clinical trials program to bring novel immunotherapies to patients at our centre.
Specific projects include:
Use of genomic technologies to map the immune response to ovarian, breast, prostate, and lymphoid cancers before, during and after standard therapy
Development of novel target antigens and immuno-modulatory strategies for vaccine- and cell-based cancer therapies
Nelson Lab
Members
Faculty/Leaders

Dr. Phineas Hamilton, PhD
Research Associate

Dr. Brad Nelson, PhD
Distinguished Scientist and Director, Deeley Research Centre

Dr. Julie Nielsen, PhD
Staff Scientist

Dr. John Webb, PhD
Senior Project Leader
Staff

Mitch Adamson, BSc, MSc
Research Assistant II

Kayla Clark, BSc.
Research Assistant I Immunotherapy Team

Tyler Dyer
RESEARCH ASSISTANT I IMMUNOTHERAPY TEAM

Megan Fuller
Research Assistant III

Nicole Gierc
Research Assistant II Immunotherapy Team

Talia Goodyear, BSc
Research Intern

Richard Hogg, BSc, MSc
RESEARCH ASSISTANT II IMMUNOTHERAPY TEAM

Shreena Kalaria, BSc
Research Assistant II

Bianca Loveless, BSc, MSc
Research Assistant II Immunotherapy Team

Katy Milne, B.Sc.
Research Projects Coordinator,

Alexi Pearson-Lund, BSc
Research Assistant I
Tashi Rastogi, BSc
Research Assistant II
Post-Docs

Céline Laumont, PhD
Postdoctoral Fellow

Alex Rodriguez, PhD
Postdoctoral Fellow
Students/Trainees

Allyson Banville
Graduate Student

Mia Dokken
Co-op Student

Monica Fuss
Honours Student

Mary Maguire
Co-op Student

Karanvir Singh
Volunteer Student
Julian Smazynski
Graduate Student

Sidney Thiessen
Co-op Student
BC Cancer Foundation is the fundraising partner of BC Cancer, which includes BC Cancer Research. Together with our donors, we are changing cancer outcomes for British Columbians by funding innovative research and personalized treatment and care.